Latest Financials News

Vital Metals has locked in firm commitments for an extra $5.6 million placement, building on its August raise, to accelerate development of its Tardiff rare earths deposit in Canada.

Compumedics has secured a $2.15 million placement to fast-track commercialisation of its Somfit D device following early FDA approval, positioning the company for significant growth in the US home sleep testing market.

Origin Energy reported a robust FY25 with a $1.48 billion profit and increased dividends, while reaffirming its commitment to net zero emissions by 2050 through its updated Climate Transition Action Plan.

Great Dirt Resources reports promising lithium soil anomalies in Western Australia's Pilbara region and progresses manganese exploration in New South Wales, supported by a solid cash position of $2.4 million.

Cann Group Limited has extended the expiry of its National Australia Bank debt facilities by one year to October 2025, maintaining current terms while exploring long-term refinancing options.

Emyria has secured a multi-year funding extension with Medibank to launch its Empax mental health programs in Brisbane, marking a key step in its national expansion. This insurer-backed initiative aims to improve access to treatment for complex conditions like treatment-resistant depression and PTSD.

Resolute Mining has agreed to support the sale of its 31.45 million shares in Loncor Gold to Chengtun Mining Group for C$1.38 per share, a move that will strengthen its balance sheet and accelerate key African projects.

SenSen Networks reported a record first quarter for FY26 with $4.3 million in cash receipts and positive operating cashflow, driven by new contracts across Singapore, the USA, and Australia. The company’s AI platform SenDISA continues to expand its footprint in Smart City solutions.

Evolution Mining delivered a record $366 million net mine cash flow in the September quarter, advancing key projects and reducing gearing to 11%, positioning itself strongly for FY26.

Actinogen Medical has secured an initial $5.5 million R&D tax incentive rebate from the Australian Tax Office, with an additional $1.9 million pending, bolstering funding for its Alzheimer’s and depression drug trials.

Ryder Capital Limited has announced a 20% increase in its annual dividend, moving to quarterly payments starting January 2026, enhancing income certainty for shareholders.

Savannah Goldfields is advancing steadily towards resuming gold production at its Georgetown project, with plant maintenance on track and significant ore haulage underway.